Phase I/II Study of the Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients with Newly Diagnosed Malignant Glioma

Grant

Date/time Interval

  • June 4, 2012 - December 31, 2018
  • Total Award Amount

  • 6000.00
  • Direct Costs

  • 4096.00
  • Sponsor Award Id

  • Contributor

  • Nabors M.D., Louis   Principal Investigator